Melinosky Kelsey, Leng Albert, Johnson Christopher R, Giuliano Verdi Katherine, Etchill Eric W, Tandri Harikrishna, Brock Malcolm V, Ha Jinny S
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Division of Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Innovations (Phila). 2023 Nov-Dec;18(6):512-518. doi: 10.1177/15569845231210282. Epub 2023 Nov 24.
Cardiac sympathetic denervation (CSD) is a surgical antiadrenergic procedure that can reduce sustained ventricular tachyarrhythmia (VT). Video-assisted thoracoscopic surgery (VATS) is currently the standard approach used in CSD, and the practicality for robot-assisted thoracoscopic surgery (RATS) has yet to be investigated.
We conducted a single-center retrospective study of all adult patients ( = 67) who underwent CSD from 2015 to 2021. We compared short-term outcomes of those treated with RATS versus VATS thoracic sympathectomy. For patients with VT, we examined the effectiveness of a RATS approach in reducing implantable cardioverter defibrillator (ICD) shock burden.
A total of 34 patients underwent RATS cardiac denervation, and 33 underwent VATS cardiac denervation. Those undergoing RATS denervation had a significantly shorter procedure duration with a median of 129 min ( = 0.008). Patients receiving the VATS approach were significantly more complicated by pneumothorax ( = 0.004) and overall complications ( = 0.01) when compared with the RATS approach. At 1 year after surgery, both groups had significant reductions in ICD shocks compared with before surgery, both decreasing from a median of 4 to 0 shocks ( < 0.001). In addition, at 1 year after surgery, the percentage of patients with persistent ICD shocks and the median of ICD shocks were similar between the groups.
The RATS approach to cardiac denervation has similar 1-year follow-up outcomes in reducing recurrent VT as the VATS approach. However, patients undergoing RATS denervation experienced better perioperative outcomes. This shows promise for robotic CSD to be an effective and safe therapeutic option for patients with malignant arrhythmias.
心脏交感神经去神经支配术(CSD)是一种外科抗肾上腺素能手术,可减少持续性室性心律失常(VT)。电视辅助胸腔镜手术(VATS)是目前CSD中使用的标准方法,而机器人辅助胸腔镜手术(RATS)的实用性尚未得到研究。
我们对2015年至2021年接受CSD的所有成年患者(n = 67)进行了单中心回顾性研究。我们比较了接受RATS与VATS胸交感神经切除术治疗的患者的短期结局。对于VT患者,我们检查了RATS方法在减轻植入式心律转复除颤器(ICD)电击负担方面的有效性。
共有34例患者接受了RATS心脏去神经支配术,33例接受了VATS心脏去神经支配术。接受RATS去神经支配术的患者手术时间明显更短,中位数为129分钟(P = 0.008)。与RATS方法相比,接受VATS方法的患者气胸(P = 0.004)和总体并发症(P = 0.01)明显更多。术后1年,与术前相比,两组的ICD电击次数均显著减少,中位数均从4次降至0次(P < 0.001)。此外,术后1年,两组间持续性ICD电击患者的百分比和ICD电击次数中位数相似。
RATS心脏去神经支配术在减少复发性VT方面与VATS方法具有相似的1年随访结局。然而,接受RATS去神经支配术的患者围手术期结局更好。这表明机器人CSD有望成为恶性心律失常患者有效且安全的治疗选择。